4.7 Article

Grb2-related adaptor protein GRAP is a novel regulator of liver fibrosis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Gastroenterology & Hepatology

Regulatory role and translational potential of CCL11 in liver fibrosis

Ming Kong et al.

Summary: This study reveals the important role of CCL11 in liver fibrosis, demonstrating that it promotes the trans-differentiation of hepatic stellate cells into myofibroblasts and mediates the development of liver fibrosis. Blocking CCL11 signaling can be considered an effective therapeutic approach for liver fibrosis.

HEPATOLOGY (2023)

Article Biochemistry & Molecular Biology

MKL1 fuels ROS-induced proliferation of vascular smooth muscle cells by modulating FOXM1 transcription

Teng Wu et al.

Summary: ROS promotes vascular smooth muscle proliferation by activating the MK-2/MKL1/FOXM1 axis, which leads to vascular injury and neointima formation. Targeting the MK-2/MKL1/FOXM1 axis may be a promising approach for the treatment of restenosis.

REDOX BIOLOGY (2023)

Review Gastroenterology & Hepatology

Health disparities in chronic liver disease

Ani Kardashian et al.

Summary: The syndemic of hazardous alcohol consumption, opioid use, and obesity has led to important changes in liver disease epidemiology that have exacerbated health disparities. Understanding how social and structural factors cause health disparities and affect chronic liver disease outcomes is crucial for improving liver health outcomes.

HEPATOLOGY (2023)

Article Medicine, Research & Experimental

Collagen matricryptin promotes cardiac function by mediating scar formation

Gabriel A. Grilo et al.

Summary: A peptide mimetic called p1159, derived from collagen, was found to reduce left ventricular dilation and fibrosis in a mouse model of myocardial infarction. This study aimed to test the potential of p1159 to reduce adverse cardiac remodeling in a chronic MI model and to elucidate its mode-of-action. The results showed that p1159 significantly improved systolic function post-MI and promoted the formation of a compliant and organized infarct scar, leading to reduced adverse cardiac remodeling.

LIFE SCIENCES (2023)

Article Medicine, Research & Experimental

Myocardin-related transcription factor A, regulated by serum response factor, contributes to diabetic cardiomyopathy in mice

Li Liu et al.

Summary: In this study, the involvement of MRTF-A, a transcriptional regulator, in diabetic cardiomyopathy was investigated. The results showed that MRTF-A was up-regulated in the hearts of mice with diabetic cardiomyopathy. Mechanistically, SRF bound to the MRTF-A gene promoter and activated its transcription in response to pro-diabetic stimuli. Deletion of MRTF-A in cardiomyocytes exacerbated the deterioration of cardiac function in mice with diabetic cardiomyopathy.

LIFE SCIENCES (2023)

Article Medicine, Research & Experimental

Bone mesenchymal stem cells promote gastric cancer progression through TGF-ll1/Smad2 positive feedback loop

Mengke Fan et al.

Summary: This study explored the exact role and potential mechanism of bone marrow-derived mesenchymal stem cells (BMSCs) in the progression of gastric cancer (GC). The researchers found that TGF-ll1 was overexpressed in GC cells and tissues and was positively related to poor prognosis. TGF-ll1 from GCs activated the Smad2 pathway in BMSCs, promoting their differentiation into carcinoma-associated fibroblasts (CAFs) and TGF-ll1 expression. Simultaneously, TGF-ll1 secreted by CAFs activated Smad2 signaling in GC cells, inducing their epithelial-mesenchymal transition (EMT) and TGF-ll1 secretion. BMSCs significantly promoted the proliferation, migration, and invasion of GCs, and blocking the TGF-ll1/Smad2 positive feedback loop reversed these effects.

LIFE SCIENCES (2023)

Article Medicine, Research & Experimental

Targetable Brg1-CXCL14 axis contributes to alcoholic liver injury by driving neutrophil trafficking

Nan Li et al.

Summary: In this study, we found that the Brg1 gene plays a crucial role in the development of alcoholic liver disease (ALD) and has potential implications for ALD intervention. Brg1 expression was increased in ALD mouse models, alcohol-exposed hepatocytes, and human ALD specimens. Manipulation of Brg1 expression in hepatocytes affected ALD development in mice. The deficiency of Brg1 specifically attenuated hepatic infiltration of Ly6G(+) neutrophils in ALD mice. Furthermore, the study identified CXCL14 as a potential target for Brg1, and manipulation of CXCL14 expression affected ALD pathogenesis.

EMBO MOLECULAR MEDICINE (2023)

Article Gastroenterology & Hepatology

C-C motif chemokine CCL11 is a novel regulator and a potential therapeutic target in non-alcoholic fatty liver disease

Zhiwen Fan et al.

Summary: This study found that CCL11 plays a regulatory role in the pathogenesis of non-alcoholic fatty liver disease (NAFLD). Inhibition or knockout of CCL11 can attenuate the pathological changes of NAFLD, including reduced body weight gain, improved insulin sensitivity, decreased lipid accumulation, and weakened liver fibrosis. Additionally, there is a positive correlation between CCL11 expression and NAFLD parameters in human patients.

JHEP REPORTS (2023)

Article Biochemistry & Molecular Biology

An MRTF-A-ZEB1-IRF9 axis contributes to fibroblast-myofibroblast transition and renal fibrosis

Qianwen Zhao et al.

Summary: This study found that myofibroblasts play an important role in renal fibrosis. By deleting myocardin-related transcription factor A (MRTF-A), the researchers discovered that MRTF-A promotes renal fibrosis by activating the transcription of Zeb1 and IRF9. These findings reveal a potential pathway for treating renal fibrosis.

EXPERIMENTAL AND MOLECULAR MEDICINE (2023)

Review Gastroenterology & Hepatology

Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases

Pere Gines et al.

Summary: Cirrhosis is a highly prevalent global disease caused mainly by non-alcoholic fatty liver disease and alcohol-related liver diseases. Noninvasive methods can accurately assess liver fibrosis, and screening high-risk populations for liver fibrosis may have the potential to prevent disease progression.

HEPATOLOGY (2022)

Article Cell Biology

Trans-activation of eotaxin-1 by Brg1 contributes to liver regeneration

Zhiwen Fan et al.

Summary: Infiltration of eosinophils is associated with and contributes to liver regeneration. Eotaxin-1 expression is elevated in proliferating murine livers and can be stimulated by hepatocyte growth factor (HGF). Brg1 is a chromatin remodeling protein that directly binds to the eotaxin promoter to activate its transcription, and interacts with NF-kappa B/RelA to activate eotaxin transcription. Depletion of eotaxin or Brg1 deficiency delays liver regeneration.

CELL DEATH & DISEASE (2022)

Article Medicine, Research & Experimental

Angiotensin II can trigger HSC-LX2 pyroptosis through both classical and non-classical pathways

Ze-yu Xie et al.

Summary: This study identifies the regulatory pathways involved in pyroptosis of HSC-LX2 cells during AngII-ROS-induced HSC activation. The results show that the classical pathway (NLRP3/Caspase-1) and non-classical pathway (Caspase-4 and-5) are responsible for HSC-LX2 pyroptosis, which is activated by AngII through ROS production.

LIFE SCIENCES (2022)

Review Gastroenterology & Hepatology

Molecular and cellular mechanisms of liver fibrosis and its regression

Tatiana Kisseleva et al.

Summary: Chronic liver injury results in liver inflammation and fibrosis, which can be reversed by eliminating activated myofibroblasts and resorbing the fibrous scar. Understanding the molecular mechanisms underlying liver fibrosis and its reversibility can lead to the identification of new therapeutic targets for liver fibrosis treatment.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Increasing Economic Burden in Hospitalized Patients With Cirrhosis: Analysis of a National Database

Archita P. Desai et al.

CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2019)

Article Genetics & Heredity

Ablation of serum response factor in hepatic stellate cells attenuates liver fibrosis

Ming Kong et al.

JOURNAL OF MOLECULAR MEDICINE-JMM (2019)

Article Cell Biology

A cAbl-MRTF-A Feedback Loop Contributes to Hepatic Stellate Cell Activation

Yunjie Lu et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)

Article Multidisciplinary Sciences

Grb2 and GRAP connect the B cell antigen receptor to Erk MAP kinase activation in human B cells

Kanika Vanshylla et al.

SCIENTIFIC REPORTS (2018)

Review Gastroenterology & Hepatology

The Origin of Fibrogenic Myofibroblasts in Fibrotic Liver

Tatiana Kisseleva

HEPATOLOGY (2017)

Article Medicine, Research & Experimental

Role of growth factor receptor-bound 2 in CCl4-induced hepatic fibrosis

Shanfei Ge et al.

BIOMEDICINE & PHARMACOTHERAPY (2017)

Article Pharmacology & Pharmacy

Ruboxistaurin attenuates diabetic nephropathy via modulation of TGF-1/Smad and GRAP pathways

Asma S. AL-Onazi et al.

JOURNAL OF PHARMACY AND PHARMACOLOGY (2016)

Article Cardiac & Cardiovascular Systems

The Actin-MRTF-SRF Gene Regulatory Axis and Myofibroblast Differentiation

Eric M. Small

JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2012)

Article Biochemistry & Molecular Biology

Quantitative mass spectrometry of diabetic kidney tubules identifies GRAP as a novel regulator of TGF-β signaling

Timothy D. Cummins et al.

BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2010)

Review Gastroenterology & Hepatology

Evolving challenges in hepatic fibrosis

Scott L. Friedman

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2010)

Article Gastroenterology & Hepatology

Stellate Cell Contraction: Role, Regulation, and Potential Therapeutic Target

Russell K. Soon et al.

CLINICS IN LIVER DISEASE (2008)

Article Gastroenterology & Hepatology

Antibody-targeted myofibroblast apoptosis reduces fibrosis during sustained liver injury

Angela Douglass et al.

JOURNAL OF HEPATOLOGY (2008)

Article Biochemistry & Molecular Biology

Grap negatively regulates T-cell receptor-elicited lymphocyte proliferation and interleukin-2 induction

R Shen et al.

MOLECULAR AND CELLULAR BIOLOGY (2002)

Review Biochemistry & Molecular Biology

Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury

SL Friedman

JOURNAL OF BIOLOGICAL CHEMISTRY (2000)